In cancer, MMP-26 expression is upregulated in human breast ductal carcinoma in situ, related to invasion 45, and in prostate cancer peaking of MMP-26 and TIMP-4 marks the invasive transition 46. This evidence concerns the gene MMP26 and cancer.